Consolidated Sep 2026 results approved; no proceeds deviation
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Consolidated Sep 2026 quarter: the provided text has no group figures or year-earlier comparison, so performance trends cannot be confirmed. The board approved unaudited standalone and consolidated quarter and half-year results; the limited review found no material misstatement. Subsidiary IOGEMS posted quarterly revenue of Rs 21.86 lakh and a Rs 51.89 lakh comprehensive loss after tax. No deviation was found in equity issue proceeds use.
No deviation in equity issue proceeds use is reassuring. Missing comparison figures limit assessment of earnings and stock price effects.
The filed figures for this quarter have not reached us in XBRL yet, so there is nothing to compute here; the read above is the AI's, from the document. The table appears the moment the figures land.